Table 3. Results of univariate and multivariate analyses of the overall survival of NUDT5.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (years) | ||||
<65 | 1 | |||
≥65 | 0.892 [0.571–1.395] | 0.617 | ||
Gender | ||||
Male | 1 | |||
Female | 0.604 [0.348–1.049] | 0.073 | ||
Lymph node metastasis | ||||
No | 1 | |||
Yes | 1.377 [0.766–2.473] | 0.285 | ||
AJCC stage | ||||
I + II | 1 | 1 | ||
III + IV | 3.675 [1.896–7.126] | <0.001* | 1.717 [0.890–3.311] | 0.107 |
T stage | ||||
T1 + T2 | 1 | |||
T3 + T4 | 2.615 [1.249–5.477] | 0.011* | 1.630 [0.713–3.726] | 0.247 |
N stage | ||||
N0 | 1 | 1 | ||
N1 + N2 | 2.065 [1.249–3.293] | 0.002* | 0.760 [0.223–2.594] | 0.661 |
Differentiation | ||||
Well + Moderate | 1 | |||
Poor | 0.951 [0.584–1.549] | 0.841 | ||
Vascular invasion | ||||
No | 1 | |||
Yes | 1.193 [0.435–3.271] | 0.731 | ||
NUDT5 | ||||
Low | 1 | 1 | ||
High | 2.084 [1.280–3.393] | 0.003* | 1.751 [1.056–2.903] | 0.030* |
Notes:
P < 0.05.
HR, hazard ratio.